Balveen Kaur, Ph.D.

Education

研究所

Biotechnology; Banaras Hindu University, Varanasi, India

Doctorate

Biochemistry and Molecular Biology Emory University, Atlanta, GA

兴趣范围

beplay苹果手机能用吗研究兴趣

出版物

出版信息

Peer Reviewed Articles:

1. Kaur B, Avery AM and Doetsch PW.: Expression, Purification, and Characterization of Ultraviolet DNA Endonuclease from Schizosaccharomyces pombe. Biochemistry. 37(33): 11599-11604, 1998.
2. Avery AM，Kaur B，Taylor JS，Mello JA，Essigmann JM和Doetsch PW。：来自Schizosacachomychorces Pombe的紫外线DNA核酸酶（UVDE/UVE1P）的底物特异性。核酸研究。beplay苹果手机能用吗27（11）：2256-2264，1999。
3. Kaur B，Fraser JL，Freyer G，Davey S和Doetsch PW。：schizosacachomyces Pombe的UVE1P介导的不匹配修复途径。分子和细胞生物学。19（7）：4703-4710，1999。
4. Kaur B和Doetsch PW。：紫外线损伤核酸内切酶（UVE1P）：结构和链特异性DNA核酸内切酶。生物化学。39（19）：5788-5796，2000。
5. Majbeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG.: Geldanamycin induces degradation of HIF-1α protein via the proteosome pathway in prostate cancer cells. Cancer Research. 62(9): 2478-2482, 2002.
6. Fulci G, Nobuaki I, Daniela M, Gernert KM, Hainaut P, Kaur B, Van Meir EG.: Initiation of human astrocytoma by clonal evolution of cells with progressive loss of functions in a patient with a 283H p53 germ line mutation. Cancer Research. 62(10): 2897-905, 2002. (Featured on Cover).
7. Brat DJ, Castellano-Sanchez A, Kaur B, Van Meir E.: Genetic and biologic progression in astrocytoma and their relation to angiogenic dysregulation. Adv. Anat. Pathol. 1(24-36), 2002.
8. Kaur B Brat DJ, Calkins CC, Van Meir E.: Brain Angiogenesis Inhibitor 1 (BAI1) is differentially expressed in the normal brain and glioblastoma independently of p53 expression. Am. J. Pathol. 162(1): 19-27, 2003.
9. Brat DJ, Kaur B, Van Meir EG. Genetic Modulation of hypoxia induced gene expression and angiogenesis: Relevance to brain tumors. Frontiers in Bioscience. 8:D100-16, 2003.
10. Brat DJ，Hunter SB，Pecot MP，Cohen C，Hammond EH，Devi NS，Kaur B，Van Meir Eg。：胶质母细胞瘤中的假钙质是缺氧，表达细胞外基质蛋白酶，并可能代表活跃的细胞群体。癌症研究。beplay苹果手机能用吗64（3）：920-927，2004。
11. Kaur B, Tan C, Brat DJ, Van Meir EG.: Genetic and hypoxic regulation of angiogenesis in gliomas. J Neuro-Oncology. 70(2):229-43, 2004.
12. Post de，Devi NS，Li Z，Brat DJ，Kaur B，Nicholson A，Olson JJ，Zhang Z，van Meir EG。：癌症治疗，具有针对肿瘤低氧微环境的复制腺病毒。临床癌症研究。beplay苹果手机能用吗10（24）：8603-12，2004
13. *Kaur B. Khwaja FK, Severson EA, Matheny S, Brat DJ, Van Meir EG.: Hypoxia and the HIF pathway in glioma growth and angiogenesis. Neuro-Oncology. 7(2):134-153, 2005
14. Kaur B，Brat DJ，Devi NS，Van Meir Eg。Vasculostatin，一种天然的BAI1蛋白水解片段是一种抗血管生成和抗肿瘤因子。（2005）癌基因24：3632-3642。
15. Fulci G, Breymann L, Gianni D, Kurozumi K, Rhee SS, Yu J, Kaur B, Louis DN, Weissleder R, Caligiuri MA, Chiocca EA.: Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proceedings of the National Academy of Sciences USA. 103(34): 12873-12878, 2006.
16. Cutter, JL, Kurozumi, K, Chiocca EA, Kaur, B.: Gene therapeutics: The future of brain tumor therapy? Expert Review of Anticancer Therapy 6(7):1053-64, 2006.
17. Lamfers ML, Fulci G, Gianni D, Tang Y, Kurozumi K, Kaur B, Moeniralm S, Saeki Y, Carette JE, Weisledder R, Vandertop WP, Beusechem VW, Dirven CMF, Chiocca EA.: Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma bearing mice monitored by bioluminescence imaging. Molecular Therapy. 14: 779-788, 2006.
18. Fulci G, Dmitrieva N, Gianni D, Fontana EJ, Pan X, Kaur B, Lawler SE, Lee RJ, Marsh CB, Brat DJ, Rooijen NV, Rachamimov AS, Weissleder R, Martuza RL, Chiocca EA.: Depletion of macrophages or microglia increases the titers of injected oncolytic viruses. Cancer Research. 67(19):9398-406, 2007.
19. Hardcastle J，Kurozumi K，Chiocca EA，Kaur B。：由肿瘤特异性启动子驱动的溶瘤病毒。当前的癌症药物靶标。7（2）：181-189，2007。
20. *Kurozumi K, Hardcastle J, Thakur R, Yang M, Christoforidis G, Fulci G, Hochberg FH, Weissleder RW, Carson W, Chiocca EA, Kaur B.: Modulation of Tumor microenvironment to enhance Oncolytic virus therapy. Journal of National Cancer Institute. 99(23):1768-81, 2007. *Accompanied by an editorial in JNCI.
21. Kurozumi K，Hardcastle J，Thakur R，Shroll J，Chiocca EA，Kaur B。：肿瘤HSV-1的肿瘤感染会诱导血管生成并上调CYR61。分子疗法。16（8）：1382-91，2008。
22. Haseley A, Alvarez-Breckenridge C Chaudhury AR, Kaur B.: Advances in Oncolytic virus Therapy for Glioma. Recent Patents on CNS Drug Discovery. 4(1): 1-13, 2009.
23. Kaur B，Cork SM，Sandberg E，Devi NS，Zhang Z，Klenotic PA，Febbraio M，Shim H，Mao H，Tucker-Burden C，Silverstein RL，Brat DJ，Olson JJ，Olson JJ和Van Meir Eg。：Vasculostatinin通过CD36依赖性机制抑制颅内神经胶质瘤的生长，并对体内血管生成进行负调节。癌症研究。beplay苹果手机能用吗69（3）：1212-20，2009。
24. Barth RF, Kaur B.: Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of Neuro-oncology. 94(3):299-312, 2009.
25. Alvarez-Breckenridge C, Kaur B and Chiocca EA.: Pharmacologic and chemical adjuvants in tumor virotherapy. Chemical reviews 109(7): 3125-3140, 2009.
26. Kaur B，Cripe T，Chiocca EA。：“购买一个免费：”用于治疗癌细胞及其微环境的武装病毒。当前的基因疗法。9（5）：341-355，2009。
27. Hardcastle J，Kurozumi K，Dmitrieva N，Sayers MP，Ahmad S，Waterman P，Weissleder R，Chiocca EA，Kaur B。：增强了Vasculostatin（VSTAT120）表达抗肿瘤的抗肿瘤功效，表达了势利的HSV-1。分子疗法18（2）：285-294，2010。
28. Klenotic PA, Huang P, Palomo J, Kaur B, Van Meir EG, Vogelbaum MA, Febbraio M, Gladson CL, Silverstein RL.: Histidine-rich glycoprotein modulates the anti-angiogenic effects of Vasculostatin. American Journal of Pathology 176(4):2039-50, 2010.
29. Nakashima H，Kaur B，Chiocca EA。细胞因子和生长因子评论。21（2-3）：119-126，2010。
30. Wojton J，Kaur B。：肿瘤微环境对溶瘤病毒疗法的影响：细胞因子和生长因子评论。21（2-3）：127-134，2010。
31. *Dmitrieva N, Yu L, Viapiano M, Chiocca EA, Cripe T, Glorioso J, Kaur B.: Choindroitinase ABC I enhances intra-tumor distribution and anti-tumor efficacy of oncolytic virus. Clinical Cancer Research. 17(6):1362-1372, 2011. *Accompanied by research highlights in Molecular therapy. PMC3140790
32. Williams SP，Nowicki MO，Liu F，Press R，Godlewski J，Abdel-Rasoul M，Kaur B，Kaur B，Fernandez SA，Chiocca ea Lawler SE。：Indirubins通过阻止肿瘤和Stromal的迁移表型来减少神经胶质瘤的生长和入侵内皮细胞室。癌症研究。beplay苹果手机能用吗71（16）：5374-80，2011。
33. Chiocca EA, Aguilar LK, Bell S, Kaur B, Hardcastle J, Cavaliere R, McGregor J, Lo S, RayChaudhuri A, Chakarvarti AG, Herbert JN, Harris KS, Grossman RG, Trask TW, Baskin DS, Monterroso CM, Manzanera AG, Aguilar-Cordova E, New PZ.: Phase Ib Study of Gene Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma. Journal of Clinical Oncology 29(27):3611-9, 2011.
34. Yoo JY, Haseley A, Bratasz A, Chiocca EA, Zhang JY, Cain D, Powell K, Kaur, B.: Antitumor Efficacy of 34.5ENVE: a transcriptionally retargeted and Vstat120 expressing oncolytic virus. Molecular Therapy. 20(2):287-97, 2012.
35. Cork SM，Kaur B，Devi NS，Cooper L，Saltz JH，4，Sandberg EM，Kaluz S，Van Meir Eg。：Furin/MMP-14蛋白水解级联反应从肿瘤抑制Bai1中释放出40 kDa Vasculestatin的小说。Oncogene 13; 31（50）：5144-52，2012。
36. Kaur B, Chiocca EA, Cripe TP.: Oncolytic HSV-1 virotherapy; Clinical experience and opportunities for progress. Current Pharmaceutical Biotechnology, Special Issue “Virotherapy”. 1:13(9):1842-51, 2012.
37. Alvarez-Breckenridge C，Yu J，Price R，Wei M，Wang Y，Nowicki P，Yoonhee M，Bergin S，Hwang C，Soledadad F，Kaur B，Caligiuri M，Caligiuri M，Chiocca EA。NK细胞对溶瘤病毒感染的胶质母细胞瘤细胞的作用，抑制了STAT5/T-BET信号传导和IFNGAMMA的产生。病毒学杂志86（8）：4566-77，2012。
38. *Haseley A，Boone S，Wojton J，Yu L，Yoo JY，Yu J，Yu J，Kurozumi K，Glorioso J，Caligiuri M，Kaur B。：细胞外基质基质蛋白CCN1 CCN1限制了神经膜瘤中的溶性功效。癌症研究，72beplay苹果手机能用吗（6）：1353-62，2012。 *伴随着分子疗法的研究重点。
39. Alvarez-Breckenridge C, Yu J, Kaur B, Caligiuri M, Chiocca EA.: Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells. Advances in Virology. doi:10.1155/2012/702839, 2012.
40. Suh S，Yoo JY，Nuovo GJ，Jeon YJ，Kim S，Lee TJ，Kim T，Bakacs A，Bakacs A，Alder H，Kaur B，Aqeilan RI，Pichiorri F，Croce CM。：Mir-25/32 Restore P53活动。MicroRNAS/TP53多形胶质母细胞瘤中的反馈电路。美国国家科学院论文集。09（14）：5316-21，2012。
41. Wurdinger T, Gatson NN, Balaj L, Kaur B, Breakefield X, Pegtel DM.: Extracellular Vesicles and the Convergence with Viral Pathways. Advances in Virology, doi: 10.1155/2012/767694, 2012.
42. Yoo JY，Pradarelli J，Haseley A，Wojton J，Kaka A，Bratasz A，Alvarez-Breckenridge C，Powell K，Pan Q，Mazar A，Teknos T，Teknos T，Old M，Chiocca EA，Glorioso J，Glorioso J，Kaur B。：通过增加其血清稳定性和抑制血管生成，铜螯合抗肿瘤的功效。临床癌症研究，18（18）：49beplay苹果手机能用吗31-41，2012
43. Gatson N, Chiocca EA, Kaur B.: Anti-angiogenic Gene Therapy in the Treatment of Malignant Gliomas. Neuroscience Letters. 527(2):62-70, 2012.
44. Onishi M, Ichikawa T, Kurozumi K, Fujii K, Yoshida K, Inoue S, Michiue H, Chiocca EA, Kaur B, Date I.: Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models. Neuropathology. 33(2):162-74, 2013.
45. Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, Moretta A, Caligiuri M, Chiocca EA.: NK cells impede glioblastoma virotherapy via NKp30 and NKp46 natural cytotoxicity receptors. Nature Medicine. 18(12):1827-34, 2012.
46. Uchida H，Marsulli M Yoo JY，Haseley A，Mazzacurati L，Nakano K，Goins WF，Hong CS，Chan J，Chan J，Baek H，Kwon H，Kwon H，Kumagai I，Kumagai I，Kuroki M，Kuroki M，Kaur B，Chiocca EA，Grandi P，Grandi P，Grandi P，Grandi P，Grandi P，，Cohen JB和Glorioso JC。：使用EGFR重新定位的OHSV有效治疗胶质母细胞瘤。分子疗法。21（3）：561-9，2013
47. Currier M，Eshun FK，Sholl A，Chernoguz，Crawford K，Divanovic S，Boon L，Goins WF，Frischer JS，Collins JS，Collins MH，Leddon JF，Baird JF，Baird WH，Haseley A，Streby KA，Streby KA，Wang P，Wang P，Hendrickson BW，Hendrickson BW，Hendrickson BW，Hendrickson BW，Brekkeen BW，Hendrickson BW，BrekkeenRA，Kaur B，Hildeman D，Cripe TP。：VEGF阻滞剂可以通过调节肿瘤内髓细胞细胞来促进癌癌病毒疗法。分子疗法（5）：1014-23，2013。
48. Price RL, Song J, Bingmer K, Kim TH, Dr. Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, Fernandez S, Kaur B, Rivera A, Oglesbee M, Cook C, Kwon CH. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Research, 73(11):3441-50, 2013.
49. Wojton J，Chu Z，Mathsyaraja H，Meisen W，Denton N，Kwon CH，Chow LM，Palascak M，Franco R，Bourdeau T，Thornton S，Ostrowski M，Kaur B，Kaur B和Qi X。：SAPC-DOP具有针对胶质母细胞瘤的分子疗法的抗血管生成和抗肿瘤作用。21（8）：1517-25，2013。
50.馆,Kurozumi K, T市川,Michiue H Fujii K, Ishida J, Shimazu Y, Chiocca EA, Kaur B, Date i.: Gene expression profiling of the anti-glioma effect of Cilengitide. Springer Plus 15;2(1):160, 2013.
51. Stephenson JR, Paavola KJ, Schaefer SA, Kaur B, Van Meir EG, Hall RA.: Brain Specific angiogenesis Inhibitor-1 (BAI1) signaling Regulation and enrichment in the postsynaptic density. Journal of Biological Chemistry. 288(31):22248-56, 2013.
52. ¬¬Racoma IO, Meisen WH, Kaur B, Snapka RM, Wani AW.: Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. Plos One. 8(9):e72882, 2013
53. Fujii K, Kurozumi K, Ichikawa T, Onishi M, Shimazu Y, Ishida J, Chiocca EA, Kaur B, Date I.: The integrin inhibitor cilengitide enhances the anti-glioma efficacy of Vasculostatin expressing oncolytic virus. (2013) Cancer Gene Therapy 20(8):437-44. NIHMSID: 511971.
54. Chu Z，Lasance K，Blanco V，Kwon CH，Kaur B，Frederick M，Thornton S，Lemen L，Qi X。：使用荧光SAPC-DOPS纳米胶质脑脑肿瘤和关节炎的体内光学成像。可视化实验杂志。doi：10.3791/51187，2013。
55. Okemoto K, Wagner B, Meisen H, Haseley A, Kaur B, Chiocca EA. STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells. Plos One. 8(8):e71932. doi: 10.137, 2013.
56. Okemoto K，Kasai K，Wagner B，Haseley A，Meisen H，Bolyard C，Kaur B，Chiocca EA。：DNA脱甲基化剂与溶溶性HSV1协同针对恶性神经胶质瘤临床癌症研究。beplay苹果手机能用吗19（21）：5952-9，2013。
57.燕F, Alinari L, Lustberg M,马丁K,订单o-Nieves, H, Banasavadi-Siddegowda, Y, Virk, S, Barnholtz-Sloan J, Hlavin Bell E, Wojton J, Jacob N, Chakravarti A, Nowicki O, Wu X, Lapalombella R, Datta J, Yu B, Gordon K, Haseley A, Patton JT, Smith P, Ryu J, Zhang X, Mo X, Marcucci G, Nuovo G, Kwon C, Byrd J, Chiocca EA, Li C, Sif A, Samson J, Lawler SE, Kaur B*, Baiocchi RA*.: Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma. Cancer Research 15;74(6):1752-65, 2013. * Co-corresponding
58. Yoo JY, Hurwitz B, Bolyard C, Yu J, Zhang J, Selvendiran K, Rath KS, He S, Bailey Z, Eaves D, Cripe T, Parris DS, Caligiuri MA, Old M, Kaur B.: Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic necroptic cell death. Clinical Cancer Research. 20(14):3787-98, 2014.
59. Kim TH，Song J，Kim SH，Parikh AK，Mo X，Palanichamy K，Kaur B，Yu J，Yo J，Yoon So，Nakano I，Kwon Ch。：哌lum蛋治疗灭活过氧毒素4，Exacerbates Endoperbates内质质杀伤，优先杀死了毒素高级神经胶质瘤细胞。神经肿瘤学。16（10）：1354-64，2014。
60. Thorne AH, Meisen H, Russell L, Yoo JY, Bolyard CM, Lathia JD, Rich J, Rich J, Puduvalli V, Yu J, Caligiuri M, Tridandapani S, Kaur B.: Role of CCN1 in macrophage mediated OV clearance. Molecular Therapy. 22(9):1678-87, 2014.
61. Kim Y，Lee HG，Dmitrieva N，Kim J，Kaur B，Friedman A。：ChoindroItinase ABC I介导的肿瘤病毒扩散和抗肿瘤功效的增强：一种数学模型。PLOS ONE E102499。doi：10.1371/journal.pone.0102499。Ecollection，2014年。
62. Wojton J, Meisen HM, Jacob N, Thorne A, Hardcastle J, Denton N, Chu Z, Dmitrieva N, Marbarthsh R, Van Meir EG, Kwon CH, Chakravarti A, Qi X, Kaur B.: SapC-DOPS-induced lysosomal cell death synergizes with TMZ in glioblastoma. Oncotarget. 5(20):9703-9, 2014.
63. Van Brocklyn JR, Wojton J, Meisen WH, Kellough DA, Ecsedy JA, Kaur B, Lehman NL.: Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Research 74(19):5364-70, 2014.
64. Suh S, Yoo JY, Cui R, Kaur B, Huebner K, Lee TK, Aqeilan R, Croce C.: FHIT gene Suppresses Metastasis and Epithelial-Mesenchymal Transition (EMT) in Lung Cancer through Modulation of microRNAs. PLos Genetics. 10(10):e1004652, 2014.
65. Bolyard CM，Yoo JY，Wang PY，Sainin U，Rath KS，Cripe TP，Zhang J，Selvendiran K，Kaur B。：阿霉素与34.5NVE协同，以增强针对转移性卵巢癌的抗肿瘤功效。临床癌症研究20（24）：647beplay苹果手机能用吗9-94，2014。
66. Meisen HW，Dubin S，Sizemore ST，Mathsyaraja H，Thies K，Lehman NL，Boyer P，Jaimie-Ramirez AC，JB Elder JB，Powell K，Chakravarti A，Ostrowski A，Ostrowski M，Kaur B。是乳腺癌生存和转移的预后指标，并为双重靶向疗法提供了机会。分子癌症治疗学14（1）：307-14，2015。
67. Mazzacurati L，Marzilli M，Reinhart B，Miyagawa Y，Uchida H，Goins WF，Li A，Kaur B，Caligiuri M，Cripe T，Cripe T，Chiocca N，Amankulor N，Cohen JB，Glorioso JC，Glorioso JC，Grandi P。：使用miRNA响应序列可阻止靶向复制，并提高未损坏的胶质母细胞瘤靶向溶溶性HSV的安全性。分子疗法。23（1）：99-107，2015。
68. Ammirati M1, Lamki T, Chitnis G, Yang X, Russell D, Coble D, Kaur B, Knopp M, Moore S, Ziaie B.: In vivo brain electrophoresis – a novel method for chemotherapy of CNS diseases. Expert Opin. Drug Delivery. 2015 Feb 10:1-8, 2015.
69. Lee TJ, Haque F, Shu D, Yoo JY, Li H, Yokel RA, Horbinski C, Kim TH, Kim SH, Kwon CH, Nakano I, Kaur B, Guo P, Croce CM.: RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget. 20;6(17):14766-76, 2015.
70. Jacobsen K，Russell L，Kaur B，Friedman A。：CCN1和巨噬细胞含量对神经胶质瘤病毒疗法的影响：一种数学模型。数学生物学公告。77（6）：984-1012，2015。
71. Yoo JY，Yu JG，Kaka A，Pan Q，Kumar P，Kumar B，Kumar B，Zhang J，Mazar A，Mazar A，Teknos T，Kaur B，Old M。：ATN-224增强了抗肿瘤疱疹病毒的抗肿瘤功效转移性头部和颈部鳞状细胞癌。分子疗法Oncolytics DOI：10.1038/MTO.2015.8，2015。
72. Meisen HW , Wohleb ES, Jaime-Ramirez CA, Bolyard CM, Yoo JY, Russell L, Hardcastle J, Dubin S, Muili K, Yu J, Caligiuri MA, Godbout J, Kaur B.: The impact of macrophage and microglia secreted TNFα on oncolytic HSV-1 therapy in the glioblastoma tumor microenvironment. Clinical Cancer Research 15; 21(14):3274-85, 2015. Accompanied by a Comment In Neurosurgery (2015 Aug;77(2):N18-20)
73. Han J，Chu J，Keung Chan W，Zhang J，Wang Y，Cohen JB，Victor A，Meisen WH，Kim SH，Grandi P，Wang Qe，He X，Nakano I，Chiocca E，Glorioso JC，Kaur JC，Kaur B，Kaur B，Caligiuri MA，Yu J。：针对野生型EGFR和EGFRVIII的CAR工程NK细胞增强了胶质母细胞瘤和患者衍生的胶质母细胞瘤干细胞的杀伤。Sci众议员9月9日；5：11483。doi：10.1038/srep11483，2015。
74. CanellaA, Cordero H, Sborov DW, Cascione L, Smith E, Radomska HS, Stiff A, Consiglio J, Caserta E, Rizzotto L, Zanesi N, Stefano V, Kaur B, Mo X, Byrd JC, Hofmeister CC and Pichiorri F.: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide. Oncotarget. 6(31):31134-50. doi: 10.18632/oncotarget.5290, 2015.
75. Cheng C, Ru P, Geng F, Liu J, Wu X, Cheng X, Euthine V, Hu P, Guo JY, Lefai E, Kaur B, Nohturfft A, Ma J, Chakravarti A, Guo D.: Glucose-mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth. Cancer Cell. 28(5):569-81, 2015.
76. Han J，Chen X，Chu J，Xu B，Meisen WH，Chen L，Zhang L，Zhang J，He X，Wang Qe，Chiocca EA，Kaur B，Caligiuri MA，Yu J。：TGF-β治疗增强胶质母细胞瘤病毒疗法通过抑制先天免疫反应。癌症研究。beplay苹果手机能用吗75（24）：5273-82，2015。
77. Welker AM, Jaros BD, Puduvalli VK, Imitola J, Kaur B, Beattie CE.: Standardized orthotopic xenografts in zebrafish reveal glioma cell line specific characteristics and tumor cell heterogeneity. Dis Model Mech. Dec 10. pii: dmm.022921, 2015.
78. Stiff A, Caserta E, Sborov DW, Nuovo GJ, Mo X, Schlotter YS, Canella A, Smith E, Badway J, Old M, Jaime-Ramirez AC, Yan P, Benson DM, Byrd J, Baiocchi R, Kaur B, Hofmeister CC, and Pichiorri F.: Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma. Molecular Cancer Therapeutics. 15(5):830-41. doi: 10.1158/1535-7163.MCT-15-0240-T, 2016.
79. Wojton J，Meisen WH，Kaur B。：如何训练神经胶质瘤细胞死亡：细胞死亡中的分子挑战。神经肿瘤学杂志。126（3）：377-84，2016。
80. Old M，Wise-Draper T，Wright CL，Kaur B，Teknos T。：肺癌病毒治疗的头颈癌的当前状态。世界耳鼻喉科和颈部手术杂志。2（2）：84-89，2016。
81. Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius L, Kaur B.: Design synthesis and evaluation of cisplatin containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors. Oncotargets and Therapy 2016 9:2769-81. doi: 10.2147/OTT.S99242, 2016.
82. Chen X，Han J，Chu J，Zhang L，Zhang J，Chen C，Chen L，Wang Y，Wang H，Yi L，Yi L，Elder BJ，Wang Q-E，He X，Kaur B，Chiocca EA，Yu J.：用于乳腺癌脑转移的EGFR-CAR NK细胞和单纯疱疹病毒1的组合疗法。Oncotarget。7（19）：27764-77。doi：10.18632/oncotarget.8526，2016。
83. Quispe CNE, Vicetti Miquel RD, Boyaka PN, Hall-Stoodley L, Kaur B, Trout W, Pavelko SD, Cherpes TL.: Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunology. 9(6):1571-1583. doi: 10.1038/mi.2016.22, 2016.
84. Bhallamudi YP, Xue R, Purser CM, PresleyKF, Banasavadi-Siddegowda YK, Hwang, J, Kaur B, Hammel C, Poirier MG, Lannutti JJ, Pandian RP.: .DNanofiber based paramagnetic probes for rapid real time oximetry.生物医学微论述。18（2）：38。doi：10.1007/s10544-016-0063-1，2016。
85.吴程耿F, X, X, Yoo司法院,程C,郭司法院, Mo X, Ru P, Hurwitz B, Kim S, Otero J, Puduvalli VK, Lefai E, Ma J, Nakano I, Horbinski C, Kaur B, Chakravarti A, Guo D.: Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clinical Cancer Research. 22(21):5337-5348, 2016
86. Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz B, Relation T, Yu JG, Lee TJ, Lotze MT, Zhang J, Croce C, Yu J, Caligiuri MA, Old M, Kaur B.: Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research. 22(21):5265-5276, 2016. Featured on Cover. Accompanied by a Comment in Clinical Cancer research (2016 Nov 1;22(21):5164-5166)
87. Banasavadi-Siddegowda YK，Russell L，Zhang J，Karkhanis VA，Imitola J，Baiocchi R，Kaur B。：PRMT5-PTEN分子途径调节胶质母细胞瘤干细胞的衰老和自我更新。Oncogene 36，263–274，2017。
88. Kesanakurti D，Maddirela D，Banasavadi-Siddegowda YK，Lai TH，Qamri Z，Jacob NK，Sampath D，Mohanam S，Kaur B，Puduvalli VK。：PPARγ与PPARγ的新颖互动，以调节NONOX1和NONOX1和NODX1和EPITHILIAL，- 神经胶质瘤中的间充质转变。癌基因。doi：10.1038/onc.2016.261。[EPUB在印刷前]，2017年
89. Lee TJ，Yoo JY，Shu D，Li H，Zhang J，Yu J，Jaime-Ramirez A，Acunzo M，Romano G，Cui R，Sun HL，Luo Z，Luo Z，Old M，Kaur B，Guo P，Guo P，Croce，CroceCM。：基于RNA纳米颗粒的靶向疗法，通过抑制致癌性miR-21。分子疗法。PII：S1525-0016（16）45424-9。doi：10.1016/j.ymthe.2016.11.016。[EPUB在印刷前]，2017年
90. Alena Jaime-Ramirez C，Dmitrieva N，Yoo JY，Banasavadi-Siddegowda Y，Zhang J，Realation T，Bolyard-Blessing C，Wojton J，Kaur B。：人性化软骨素酶Abc ABC ABC将Glioblastomans蛋白酶敏感到Gliobblastoma cells tomozolomamide。基因医学杂志。3月; 19（3）。doi：10.1002/jgm.2942，2017。
91. Jaime-Ramirez AC，Yu JG，Caserta E，Yoo JY，Zhang J，Lee TJ，Hofmeister C，Lee JH，Kumar B，Pan Q，Kumar P，Baiocchi R，Teknos T，Teknos T，Pichiorri F，Pichiorri F，Kaur B，Old Old，Old Old，Old Old，Old Oldm。：雷藻素和组蛋白脱乙酰基酶在治疗头颈部鳞状细胞癌分子疗法癌中的治疗中抑制。2017年5月19日在线发布。
92. Bolyard C, Meisen WH, Banasavadi-Siddegowda Y, Hardcastle J, Yoo JY, Wohleb ES, Wojton J, Yu J, Dubin S, Khosla M, Xu B, Smith J, Alvarez-Breckenridge C, Pow-anpongkul P, Pichiorri F, Zhang J, Old M, Zhu D, Van Meir EG, Godbout J, Caligiuri MA, Yu J, Kaur B.: BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research. 23(7):1809-1819, 2017.
93. Saini U，Naidu S，Elnaggar AC，Bid HK，Wallbillich JJ，Bixel K，Bolyard C，Suarez AA，Kaur B，Kuppusamy P，Hays J，Goodfellow PJ，Cohn DE，Cohn DE，Cohn DE，Selvendiran K。癌症腹水促进侵袭和转移：潜在的治疗靶点。癌基因。12; 36（2）：168-181，2017。
94. Ru P，Hu P，Geng F，Mo X，Cheng C，Yoo JY，Cheng X，Wu X，Guo JY，Nakano I，Lefai E，Kaur B，Chakravarti A，Guo D*。：反馈回路调节miR-29的SCAP/SREBP-1调节EGFR信号驱动的胶质母细胞瘤的生长。细胞报告16（6）：1527-35。doi：10.1016/j.celrep.2016.07.017，2017。
95. Jaime-Ramirez AC, Yu JG, Caserta E, Yoo JY, Zhang J, Lee TJ, Hofmeister C, Lee JH, Kumar B, Pan Q, Kumar P, Baiocchi R, Teknos T, Pichiorri F, Kaur B, Old M. Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma. (2017) Molecular Therapy Oncolytics. DOI: http://dx.doi.org/10.1016/j.omto.2017.05.002.
96. Canella A, Welker AM, Yoo JY, Xu J, Abbas FS, Kesanakurti D, Nagarajan P, Beattie CE, Sulman EP, Liu JL, Gumin J, Lang FF, Gurcan M, Kaur B, Sampath D, Puduvalli VK. Efficacy of Onalespib a Long-acting Second Generation HSP90 Inhibitor as a Single Agent and in Combination with Temozolomide against Malignant Gliomas. (2017) Clinical Cancer research. clincanres.3151.2016. doi: 10.1158/1078-0432.CCR-16-3151. [Epub ahead of print]
97. Dai HS，Griffin N，Bolyard C，Mao HC，Zhang J，Cripe TP，Suenaga T，Arase H，Nakano I，Chiocca EA，Kaur B，Yu J，Yu J，Caligiuri MA。免疫球蛋白的FC结构域足以用病毒感染的细胞桥接NK细胞。（2017）免疫力。18; 47（1）：159-170.e10。doi：10.1016/j.immuni.2017.06.019。
邀请文章（评论，社论等）
98. Kaur B, Chiocca EA.: Extreme treatment for an extreme disease. Future Microbiology. 1(4):351-353, 2006.
99. Kaur B，Chiocca EA。个性化溶瘤病毒疗法。（2007）分子疗法。15（1）：6-7。
100. Meisen H，KaurB。我们如何欺骗免疫系统来克服溶瘤病毒疗法的有害作用来治疗胶质母细胞瘤？（2013）神经疗法专家评论。13（4）：341-343。doi：10.1治疗剂的开发手册586/ern.13.25。
101. Wojton J, Elder B, Kaur B. How efficient are autophagy inhibitors as treatment for glioblastoma? 3(1) 5-7. (2014) CNS Oncology.
102. Russell L，Bolyard C，Banasavadi-Siddegowda Y，Weiss A，Zhang J，Shakya R，Powell K，KaurB。性别作为对Temozolomide的生物学变量。（2017）神经肿瘤学

Book Chapters:

103. Barth R，Kaur B。：用于新疗法的临床前治疗评估的免疫能力颅内大鼠神经瘤模型。在中枢神经系统癌中。ISBN：978-1-60327-552-1，2009。编辑：Erwin van-Meir。出版商：Springer。
104. Lee TJ, Haque F, Vieweger M, Yoo JY, Kaur B, Guo P, Croce CM.: Functional Assays for Specific Targeting and Delivery of RNA Nanoparticles to Brain Tumor. Methods in Molecular Biology. RNA nanotechnology and therapeutics. doi: 10.1007/978-1-4939-2562-9_10., 2015. © Springer Science+Business Media New York 2015
105.Kaur B, Lesinsky G,乔杜里。:从基本概念t to the Clinics: Development of Novel Large Molecule Cancer Therapeutics. Pharmaceutical Sciences Encyclopedia. DOI: 10.1002/9780470571224.pse402. 4:1-39, 2010. Editors; Shayne C. Gad. Publisher: John Wiley & Sons. DOI: 10.1002/9780470571224.pse402
106. Price R，Kaur B，Chiocca EA。：癌症治疗的单纯疱疹病毒1。在基于基因的癌症疗法中。当前的癌症研究书系列。beplay苹果手机能用吗doi：10.1007/978-1-4419-6102-0_12，2010。编辑：Jack A Roth。出版商：纽约施普林格。